Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Circle Biologics is a regenerative medicine company specializing in point-of-care orthobiologic solutions. The company's core technology, the Pro-Gen system, is designed to efficiently concentrate autologous platelets and bone marrow-derived stem cells for clinical use. These concentrated biologics are utilized in orthopedic and sports medicine settings to treat conditions such as osteoarthritis and musculoskeletal injuries. By streamlining the preparation of Platelet-Rich Plasma (PRP) and Bone Marrow Concentrate (BMC), Circle Biologics enables clinicians to leverage the patient's own healing mechanisms. The company is headquartered in Minneapolis and serves the growing demand for minimally invasive regenerative therapies. Their products focus on high-purity outputs to optimize the therapeutic potential of autologous treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Circle Biologics.